Mar 27, 2020
ThermoGenesis Holdings Announces Closing Of $3.5 Million Registered Direct Offering Priced At-the-Market
Mar 24, 2020
ThermoGenesis Holdings Announces 2019 Year End Financial Results And Provides Corporate Update
Feb 19, 2020
ThermoGenesis Holdings Announces Partial Conversion Of Revolving Credit Agreement Held By Boyalife Asset Holding II
Jan 03, 2020
ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment
Dec 05, 2019
ThermoGenesis Holdings To Present At The LD Micro 12th Annual Main Event
Nov 12, 2019
ThermoGenesis Holdings To Delay Third Quarter 2019 Earnings Release And Conference Call Until Thursday, November 14, 2019
Nov 06, 2019
ThermoGenesis Holdings To Announce Financial Results For The Third Quarter Ended September 30, 2019 And Provide A Corporate Strategic Update
Oct 24, 2019
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
Oct 14, 2019
Cesca Therapeutics To Present At The 2019 Bio Investor Forum
Oct 02, 2019
Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee
Sep 09, 2019
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
Sep 03, 2019
Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference
Aug 13, 2019
Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 23, 2019
America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II System
Jun 26, 2019
Cesca Therapeutics Regains Nasdaq Listing Compliance
Jun 25, 2019
Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India
Jun 18, 2019
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing
Jun 05, 2019
ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium
Jun 04, 2019
Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock
May 14, 2019
Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update